Vincerx Pharma, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies (NCT06034275) | Vincerx Pharma, Inc. | 2023-09-13 |
| Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer (NCT05712889) | Vincerx Pharma, Inc. | 2023-01-24 |
| A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome (NCT04978779) | Vincerx Pharma, Inc. | 2021-12-16 |
Track Vincerx Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.